Intestinal fructose metabolism triggers a glucagon-like peptide-1-β-cell axis to prevent post-fructose hyperglycaemia.
Level 5 - mechanism / opinion, no new human data
Preclinical animal and in vitro laboratory study without human participants.
PubMed 41129467 · doi:10.1113/JP289067
What was done
Researchers investigated the mechanism of fructose-induced incretin and insulin secretion across lean (NSY.B6-a/a), obese diabetic (NSY.B6-A y /a), and knockout mouse models (Gipr -/-, Gcg -/-, and Kcnj11 -/-) following 24 hours of ad libitum fructose ingestion. They tested pharmacological GLP-1 receptor antagonism and examined cellular mechanisms using the GLUTag L-cell line and 13C-labelled fructose metabolic tracing in freshly isolated mouse intestinal crypts.
What was found
In both lean and obese diabetic mice, 24-hour fructose ingestion elevated plasma insulin, GLP-1, and GIP. The insulin response was preserved in Gipr -/- mice but abolished in Gcg -/- mice and by pharmacological GLP-1 receptor antagonism. Fructolysis increased the ATP/ADP ratio and closed KATP channels in L-cells, stimulating GLP-1 secretion. No exact numerical values, effect sizes, or p-values were reported in the abstract.
Why it matters
The findings identify an intestinal fructolysis-driven GLP-1-beta-cell gut-pancreas axis in mice that counteracts post-fructose hyperglycaemia via KATP channel closure.
Limits
The study is limited to rodent models and cell lines, precluding direct extrapolation to human physiology. The abstract provides no sample sizes, specific quantitative values, or confidence intervals, and the intervention was restricted to a short-term 24-hour fructose exposure.
Cited by
- contradicts Fructose does not directly elicit an insulin response.